Jun Miki

2.8k total citations
171 papers, 1.6k citations indexed

About

Jun Miki is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Jun Miki has authored 171 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 85 papers in Surgery, 73 papers in Pulmonary and Respiratory Medicine and 33 papers in Oncology. Recurrent topics in Jun Miki's work include Bladder and Urothelial Cancer Treatments (59 papers), Urinary and Genital Oncology Studies (40 papers) and Prostate Cancer Treatment and Research (31 papers). Jun Miki is often cited by papers focused on Bladder and Urothelial Cancer Treatments (59 papers), Urinary and Genital Oncology Studies (40 papers) and Prostate Cancer Treatment and Research (31 papers). Jun Miki collaborates with scholars based in Japan, United States and Austria. Jun Miki's co-authors include Takahiro Kimura, Shin Egawa, Hiroyuki Takahashi, Bungo Furusato, Johng S. Rhim, Hongzhen Li, Yongpeng Gu, David G. McLeod, Shiv Srivastava and Takafumi Yanagisawa and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Cancer Research.

In The Last Decade

Jun Miki

157 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jun Miki Japan	19	630	559	508	457	175	171	1.6k
Jun Teishima Japan	23	838 1.3×	494 0.9×	435 0.9×	787 1.7×	400 2.3×	186	1.9k
Wataru Obara Japan	19	516 0.8×	452 0.8×	402 0.8×	440 1.0×	162 0.9×	139	1.2k
Steffen Rausch Germany	21	564 0.9×	292 0.5×	476 0.9×	497 1.1×	257 1.5×	122	1.4k
Kikuo Nutahara Japan	27	918 1.5×	321 0.6×	530 1.0×	588 1.3×	262 1.5×	107	2.1k
Tomoyasu Tsushima Japan	25	700 1.1×	304 0.5×	673 1.3×	489 1.1×	136 0.8×	101	1.6k
Liliana Montella Italy	23	436 0.7×	594 1.1×	286 0.6×	262 0.6×	204 1.2×	102	1.6k
Eric Kauffman United States	19	722 1.1×	256 0.5×	594 1.2×	730 1.6×	284 1.6×	76	1.7k
Sertaç Yazıcı Türkiye	18	379 0.6×	495 0.9×	196 0.4×	459 1.0×	173 1.0×	56	1.2k
Tatsuo Morita Japan	18	344 0.5×	394 0.7×	275 0.5×	328 0.7×	124 0.7×	100	1.1k
Burçin Tuna Türkiye	18	391 0.6×	213 0.4×	293 0.6×	284 0.6×	154 0.9×	91	1.0k

Countries citing papers authored by Jun Miki

Since Specialization

Citations

This map shows the geographic impact of Jun Miki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jun Miki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jun Miki more than expected).

Fields of papers citing papers by Jun Miki

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jun Miki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jun Miki. The network helps show where Jun Miki may publish in the future.

Co-authorship network of co-authors of Jun Miki

This figure shows the co-authorship network connecting the top 25 collaborators of Jun Miki. A scholar is included among the top collaborators of Jun Miki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jun Miki. Jun Miki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yanagisawa, Takafumi, Keiichiro Mori, Akihiro Matsukawa, et al.. (2025). Novel combination therapy for platinum-eligible patients with locally advanced or metastatic urothelial carcinoma: a systematic review and network meta-analysis. Cancer Immunology Immunotherapy. 74(3). 76–76. 1 indexed citations

Urabe, Fumihiko, Takafumi Yanagisawa, Wataru Fukuokaya, et al.. (2025). Evaluating CRPC Definition: Comparing Upfront ARSI and Conventional Hormonal Therapy for Metastatic Hormone Sensitive Prostate Cancer (mHSPC) in Real World Propensity Score Matched Cohort. The Prostate. 85(10). 912–918. 1 indexed citations

Yanagisawa, Takafumi, Akihiro Matsukawa, Jeremy Yuen‐Chun Teoh, et al.. (2025). Advancements in systemic therapy for muscle-invasive bladder cancer: A systematic review from the beginning to the latest updates. Bladder Cancer. 11(2). 1802647506–1802647506. 1 indexed citations

Miki, Jun, Wataru Fukuokaya, Rikiya Taoka, et al.. (2024). Oncological outcomes of prophylactic urethrectomy at the time of radical cystectomy for bladder cancer: A nationwide multi‐institutional study. International Journal of Urology. 31(9). 1009–1016. 1 indexed citations

Tashiro, Kojiro, Shoji Kimura, Shunsuke Tsuzuki, et al.. (2024). Radiographic Progression at Castration-Resistant Prostate Cancer Diagnosis: A Prognostic Indicator of Metastatic Hormone-Sensitive Prostate Cancer. Clinical Genitourinary Cancer. 22(3). 102075–102075. 2 indexed citations

Urabe, Fumihiko, Takafumi Yanagisawa, Wataru Fukuokaya, et al.. (2024). Changes in the treatment landscape of metastatic hormone‐sensitive prostate cancer following approval of upfront androgen receptor signaling inhibitors: A multicenter study. International Journal of Urology. 31(11). 1248–1255. 3 indexed citations

Kuroda, Takafumi, Izumi Yamamoto, Akimitsu Kobayashi, et al.. (2023). Booster effect of the third dose of SARS-CoV-2 mRNA vaccine in Japanese kidney transplant recipients. Scientific Reports. 13(1). 9976–9976. 2 indexed citations

Yanagisawa, Takafumi, Wataru Fukuokaya, Kosuke Iwatani, et al.. (2023). Percutaneous cryoablation versus partial nephrectomy for cT1b renal tumors: An inverse probability weight analysis. Urologic Oncology Seminars and Original Investigations. 41(3). 150.e11–150.e19. 7 indexed citations

Yamamoto, Izumi, Akimitsu Kobayashi, Go Kanzaki, et al.. (2023). Early Recurrence of Immunoglobulin A Nephropathy after Kidney Transplantation in a Patient with Down Syndrome. The Nephron journals/Nephron journals. 147(Suppl. 1). 35–40. 1 indexed citations

10.

Urabe, Fumihiko, Wataru Fukuokaya, Kosuke Iwatani, et al.. (2023). Prognostic significance of subclassifying pathological T3 upper tract urothelial carcinoma: Results from a multicenter cohort study. International Journal of Urology. 31(2). 125–132. 4 indexed citations

11.

Iwatani, Kosuke, Jun Miki, Fumihiko Urabe, et al.. (2023). Effectiveness of everolimus for sporadic renal angiomyolipoma with inferior vena cava thrombus: A case report. Urology Case Reports. 50. 102520–102520. 1 indexed citations

12.

Matsukawa, Akihiro, Takafumi Yanagisawa, Kensuke Bekku, et al.. (2023). Nonsurgical Interventions to Prevent Disease Progression in Prostate Cancer Patients on Active Surveillance: A Systematic Review and Meta-analysis. European Urology Oncology. 7(3). 376–400. 4 indexed citations

13.

Matsukawa, Akihiro, et al.. (2023). Feasibility of Novel Technique of Flexible Cystoscopic En Bloc Snare Resection of Bladder Tumor: f-ESRBT. Journal of Endourology. 37(6). 713–717.

14.

Yanagisawa, Takafumi, Shintaro Narita, Shingo Hatakeyama, et al.. (2023). Docetaxel versus abiraterone for metastatic hormone‐sensitive prostate cancer with focus on efficacy of sequential therapy. The Prostate. 83(6). 563–571. 4 indexed citations

15.

Yanagisawa, Takafumi, et al.. (2023). Comparison of Quality of Life and Injection Site Reactions After Switching from Degarelix 80 mg to 480 mg in Advanced Prostate Cancer: A Prospective Trial. Anticancer Research. 43(4). 1611–1621. 1 indexed citations

16.

Fukuokaya, Wataru, Takafumi Yanagisawa, Masaki Hashimoto, et al.. (2022). Effectiveness of pembrolizumab in trial-ineligible patients with metastatic urothelial carcinoma. Cancer Immunology Immunotherapy. 72(4). 841–849. 4 indexed citations

17.

Miki, Jun, Wataru Fukuokaya, Takafumi Yanagisawa, et al.. (2021). The prognostic value of the preoperative lung immune prognostic index in patients with urothelial bladder cancer undergoing radical cystectomy. International Journal of Clinical Oncology. 27(2). 396–402. 13 indexed citations

18.

Mori‐Yoshimura, Madoka, Jun Miki, Ryogen Sasaki, et al.. (2020). Paramyotonia Congenita with Persistent Distal and Facial Muscle Weakness: A Case Report with Literature Review. Journal of Neuromuscular Diseases. 7(2). 193–201. 5 indexed citations

19.

Fukuokaya, Wataru, Takahiro Kimura, Takafumi Yanagisawa, et al.. (2020). Comparison of the Immunotherapy Response Evaluation Criteria in Solid Tumours (iRECIST) with RECIST for capturing treatment response of patients with metastatic urothelial carcinoma treated with pembrolizumab. British Journal of Urology. 127(1). 90–95. 5 indexed citations

20.

Yamamoto, Izumi, Akimitsu Kobayashi, Yusuke Koike, et al.. (2017). Successful Treatment of Plasma Cell-Rich Acute Rejection Using Pulse Steroid Therapy Alone: A Case Report. SHILAP Revista de lepidopterología. 2017. 1–7. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact